TY - JOUR
T1 - Modulation of human estrogen receptor α activity by multivalent estradiol-peptidomimetic conjugates
AU - Holub, Justin M.
AU - Garabedian, Michael J.
AU - Kirshenbaum, Kent
PY - 2011/2/1
Y1 - 2011/2/1
N2 - Estradiol-peptidomimetic conjugates (EPCs) are linear, sequence-specific peptoid oligomers that site-specifically display multiple copies of 17β-estradiol (E2), a ligand for the human estrogen receptor α (hERα). We evaluate the ability of multivalent EPCs to activate hERα-mediated transcription. EPCs activated the hERα in both a length- and valence-dependent manner, with the highest levels of activation generated by divalent peptoid 6-mers, divalent 18-mers, and trivalent 9-mers. Hexavalent EPCs did not activate hERα, but instead blocked E2-mediated hERα activation. The physicochemical features of EPCs can be precisely tuned, which may allow the generation of a library of chemical tools for modulating specific effects of estrogens.
AB - Estradiol-peptidomimetic conjugates (EPCs) are linear, sequence-specific peptoid oligomers that site-specifically display multiple copies of 17β-estradiol (E2), a ligand for the human estrogen receptor α (hERα). We evaluate the ability of multivalent EPCs to activate hERα-mediated transcription. EPCs activated the hERα in both a length- and valence-dependent manner, with the highest levels of activation generated by divalent peptoid 6-mers, divalent 18-mers, and trivalent 9-mers. Hexavalent EPCs did not activate hERα, but instead blocked E2-mediated hERα activation. The physicochemical features of EPCs can be precisely tuned, which may allow the generation of a library of chemical tools for modulating specific effects of estrogens.
UR - http://www.scopus.com/inward/record.url?scp=78751669050&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78751669050&partnerID=8YFLogxK
U2 - 10.1039/c0mb00189a
DO - 10.1039/c0mb00189a
M3 - Article
C2 - 21218226
AN - SCOPUS:78751669050
SN - 1742-206X
VL - 7
SP - 337
EP - 345
JO - Molecular BioSystems
JF - Molecular BioSystems
IS - 2
ER -